TCRT · Alaunos Therapeutics, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“We require substantial additional financial resources to continue as a going concern and advance our Obesity and Metabolic Disorders Program; the failure to obtain it on acceptable terms would materially harm our business.”